PT3473621T - Método de produção de derivados de difenilmetano - Google Patents

Método de produção de derivados de difenilmetano

Info

Publication number
PT3473621T
PT3473621T PT17813615T PT17813615T PT3473621T PT 3473621 T PT3473621 T PT 3473621T PT 17813615 T PT17813615 T PT 17813615T PT 17813615 T PT17813615 T PT 17813615T PT 3473621 T PT3473621 T PT 3473621T
Authority
PT
Portugal
Prior art keywords
diphenylmethane derivative
producing diphenylmethane
producing
derivative
diphenylmethane
Prior art date
Application number
PT17813615T
Other languages
English (en)
Original Assignee
Green Cross Corp
Dae Woong Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=60664449&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT3473621(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Green Cross Corp, Dae Woong Pharma filed Critical Green Cross Corp
Publication of PT3473621T publication Critical patent/PT3473621T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D9/00Crystallisation
    • B01D9/005Selection of auxiliary, e.g. for control of crystallisation nuclei, of crystal growth, of adherence to walls; Arrangements for introduction thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B51/00Introduction of protecting groups or activating groups, not provided for in the preceding groups
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT17813615T 2016-06-17 2017-06-15 Método de produção de derivados de difenilmetano PT3473621T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR20160075910 2016-06-17

Publications (1)

Publication Number Publication Date
PT3473621T true PT3473621T (pt) 2021-10-04

Family

ID=60664449

Family Applications (2)

Application Number Title Priority Date Filing Date
PT201529591T PT3663292T (pt) 2016-06-17 2017-06-15 Derivado de difenilmetano em forma cristalina
PT17813615T PT3473621T (pt) 2016-06-17 2017-06-15 Método de produção de derivados de difenilmetano

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PT201529591T PT3663292T (pt) 2016-06-17 2017-06-15 Derivado de difenilmetano em forma cristalina

Country Status (29)

Country Link
US (2) US10640496B2 (pt)
EP (2) EP3473621B1 (pt)
JP (4) JP6763978B2 (pt)
KR (2) KR102233229B1 (pt)
CN (2) CN113651803B (pt)
AU (1) AU2017285813B2 (pt)
CA (2) CA3026756C (pt)
CL (1) CL2018003645A1 (pt)
CO (1) CO2018014018A2 (pt)
DK (2) DK3663292T3 (pt)
DO (1) DOP2018000287A (pt)
EC (1) ECSP19000185A (pt)
ES (2) ES2898336T3 (pt)
HR (1) HRP20211670T8 (pt)
HU (1) HUE056428T2 (pt)
MA (2) MA44545B2 (pt)
MX (2) MX392177B (pt)
MY (1) MY203941A (pt)
NZ (1) NZ749398A (pt)
PE (2) PE20240590A1 (pt)
PH (1) PH12018550206A1 (pt)
PL (2) PL3663292T3 (pt)
PT (2) PT3663292T (pt)
RS (1) RS62550B1 (pt)
SA (2) SA521422474B1 (pt)
SG (2) SG10201911782RA (pt)
SI (1) SI3663292T1 (pt)
TN (1) TN2018000437A1 (pt)
WO (1) WO2017217792A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102011054773A1 (de) 2011-10-25 2013-04-25 Vb Autobatterie Gmbh & Co. Kgaa Anschlusspol für einen Akkumulator, Akkumulatorgehäuse und Maschine zur Herstellung eines Anschlusspols
EP3838894B1 (en) 2018-08-13 2024-03-13 Daewoong Pharmaceutical Co., Ltd. Method for producing intermediate useful for synethesis of sglt inhibitor
CN112341416A (zh) * 2019-08-09 2021-02-09 天津津艺医药科技发展有限责任公司 一种制备苯并含氧脂杂环衍生物的方法
EP4112612B1 (en) 2020-02-27 2025-10-22 Daewoong Pharmaceutical Co., Ltd. Intermediate useful for synthesis of sglt inhibitor and method for preparing sglt inhibitor using same
CN112094253B (zh) * 2020-09-10 2023-01-10 株式会社大熊制药 用于制备sglt抑制剂中间体的合成方法
PE20231373A1 (es) 2020-09-10 2023-09-07 Daewoong Pharmaceutical Co Ltd Metodo de sintesis para la preparacion de un intermedio de inhibidores de sglt
CN113200860B (zh) * 2021-04-29 2024-07-30 爱斯特(成都)生物制药股份有限公司 一种sglt2抑制剂中间体的制备方法
KR20230046784A (ko) * 2021-09-30 2023-04-06 주식회사 대웅제약 이나보글리플로진을 포함하는 약학 조성물
CN113801010A (zh) * 2021-11-18 2021-12-17 山东诚创蓝海医药科技有限公司 一种5-溴-2-氯苯甲酸的制备方法
CN113912487B (zh) * 2021-11-23 2024-05-28 山东研峰新材料科技有限公司 一种2,5-双卤代苯甲酸的合成方法
KR20230110001A (ko) * 2022-01-14 2023-07-21 주식회사 대웅제약 Ssglt 저해제의 합성에 유용한 중간체의 제조 방법
KR20240044194A (ko) 2022-09-28 2024-04-04 주식회사 대웅제약 이나보글리플로진의 신규한 공결정
KR20240044190A (ko) 2022-09-28 2024-04-04 주식회사 대웅제약 이나보글리플로진의 신규한 결정형 및 이의 제조방법
CN119968202A (zh) 2022-09-29 2025-05-09 株式会社大熊制药 用于预防或治疗心血管衰老疾病的包含依那格列净的药物组合物
WO2024076177A1 (ko) 2022-10-05 2024-04-11 주식회사 대웅제약 이나보글리플로진을 포함하는 신장애 및/또는 당뇨병 예방 또는 치료용 약학 조성물
CN120435283A (zh) 2022-12-21 2025-08-05 大熊治疗株式会社 包含依那格列净的滴眼剂形式的药物组合物
KR20240107660A (ko) 2022-12-30 2024-07-09 주식회사 대웅제약 이나보글리플로진 및 메트포르민을 포함하는 약학 조성물
KR102837941B1 (ko) * 2024-11-13 2025-07-25 대웅바이오(주) Inline quenching 공정을 도입한 연속반응 공정을 이용한 이나보글리플로진 합성방법
KR102853437B1 (ko) * 2024-11-13 2025-09-04 대웅바이오(주) 연속반응 공정을 이용한 이나보글리플로진 합성방법
KR102837948B1 (ko) * 2024-11-13 2025-07-25 대웅바이오(주) 분배 투입법을 도입한 연속반응 공정을 이용한 이나보글리플로진 합성방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4966907A (en) * 1988-08-12 1990-10-30 Merck & Co., Inc. 6-substituted 5-hydroxy-2,3-dihydrobenzofurans as inhibitors of leukotriene biosynthesis
LT2896397T (lt) * 2003-08-01 2017-11-27 Mitsubishi Tanabe Pharma Corporation Nauji junginiai, turintys inhibitorinį aktyvumą prieš nuo natrio priklausomą gliukozės transporterį
AU2008279424B2 (en) 2007-07-26 2013-06-13 Lexicon Pharmaceuticals, Inc. Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibitors
PE20110208A1 (es) 2008-07-30 2011-03-28 Ferrer Int Compuestos de 1,6-dihidro-2h-3-oxa-6-aza-as-indaceno
US8163704B2 (en) 2009-10-20 2012-04-24 Novartis Ag Glycoside derivatives and uses thereof
WO2012041898A1 (en) * 2010-09-29 2012-04-05 Celon Pharma Sp. Z O.O. Combination of sglt2 inhibitor and a sugar compound for the treatment of diabetes
WO2012165914A2 (en) * 2011-06-01 2012-12-06 Green Cross Corporation Novel diphenylmethane derivatives as sglt2 inhibitors
US9340521B2 (en) 2013-03-18 2016-05-17 Green Cross Corporation Method for dual inhibition of SGLT1 and SGLT2 using diphenylmethane derivatives
FR3017868A1 (fr) 2014-02-21 2015-08-28 Servier Lab Derives d'isoquinoleine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
MX2018015647A (es) 2019-04-11
JP2023145481A (ja) 2023-10-11
JP7773506B2 (ja) 2025-11-19
SG11201811154QA (en) 2019-01-30
MA44545A1 (fr) 2019-10-31
CA3026756C (en) 2021-03-02
KR102233229B1 (ko) 2021-03-29
SG10201911782RA (en) 2020-02-27
RU2021129636A (ru) 2021-11-22
ECSP19000185A (es) 2019-01-31
HUE056428T2 (hu) 2022-02-28
PE20190467A1 (es) 2019-04-04
JP2020117528A (ja) 2020-08-06
HRP20211670T1 (hr) 2022-02-18
RU2019101056A3 (pt) 2020-07-17
CA3081033C (en) 2022-04-12
SA521422474B1 (ar) 2023-11-02
MY203941A (en) 2024-07-25
JP7352509B2 (ja) 2023-09-28
AU2017285813A1 (en) 2019-01-17
EP3473621B1 (en) 2021-08-04
EP3473621A4 (en) 2020-03-11
RU2019101056A (ru) 2020-07-17
MA50774B1 (fr) 2022-02-28
MA44545B2 (fr) 2020-11-30
CN109311861B (zh) 2021-08-24
EP3473621A1 (en) 2019-04-24
SA518400666B1 (ar) 2021-11-30
PH12018550206A1 (en) 2019-09-30
BR112018076243A2 (pt) 2019-03-26
EP3663292A1 (en) 2020-06-10
EP3663292B1 (en) 2021-09-01
DK3473621T3 (da) 2021-09-06
PE20240590A1 (es) 2024-03-21
NZ749398A (en) 2020-01-31
PL3473621T3 (pl) 2022-01-10
MA44545B1 (fr) 2020-05-29
US10889574B2 (en) 2021-01-12
PL3663292T3 (pl) 2022-01-17
CN113651803B (zh) 2022-10-28
ES2891825T3 (es) 2022-01-31
JP2019521985A (ja) 2019-08-08
CO2018014018A2 (es) 2019-03-08
WO2017217792A1 (ko) 2017-12-21
KR20170142904A (ko) 2017-12-28
CA3081033A1 (en) 2017-12-21
DK3663292T3 (da) 2021-10-25
ES2898336T3 (es) 2022-03-07
CN113651803A (zh) 2021-11-16
JP2021152054A (ja) 2021-09-30
CL2018003645A1 (es) 2019-03-22
US20190169174A1 (en) 2019-06-06
MX2021008988A (es) 2022-05-05
SI3663292T1 (sl) 2022-01-31
JP6763978B2 (ja) 2020-09-30
AU2017285813B2 (en) 2020-02-06
MX385640B (es) 2025-03-18
US10640496B2 (en) 2020-05-05
MX392177B (es) 2025-03-19
RS62550B1 (sr) 2021-12-31
US20190382390A1 (en) 2019-12-19
JP7669206B2 (ja) 2025-04-28
PT3663292T (pt) 2021-11-08
MA50774A1 (fr) 2021-03-31
CA3026756A1 (en) 2017-12-21
CN109311861A (zh) 2019-02-05
DOP2018000287A (es) 2019-03-31
KR20210036892A (ko) 2021-04-05
TN2018000437A1 (en) 2020-06-15
HRP20211670T8 (hr) 2022-03-18
KR102379584B1 (ko) 2022-03-29

Similar Documents

Publication Publication Date Title
SG10201911782RA (en) Method for producing diphenylmethane derivative
IL266044B (en) Method for the production of 3-alkylsulfanyl-2-chloro-n-(1-alkyl-h1-tetrazol-5-yl)-4-trifluoromethyl-benzamides
PT3352896T (pt) Método de produção de isocianatos
EP3333266A4 (en) PROCESS FOR THE PRODUCTION OF SELENOEINE
ZA201702613B (en) A footlet as well as a method for producing such a footlet
PL3227023T3 (pl) Sposób wytwarzania kropel
GB201414737D0 (en) Method for producing 3-hydroxypropanal
EP3144337A4 (en) Method for producing polyamide
SG11201701326YA (en) Method for producing oligosilane
EP3275886A4 (en) Method for producing dialkylaminosilane
IL258148B (en) Methods for producing flumetamol
IL252173A0 (en) Methods for the production of methyl dichlorophosphane
IL264307B (en) Production method for a pyrazole-amide compound
SG11201907182QA (en) Method for producing perfluoroalkadiene compounds
IL258301A (en) A method for producing phosphinates
HUE047039T2 (hu) Eljárás izocianátok elõállítására
SG11202003954QA (en) Method for producing dihydroxyindoles
SG11202004021RA (en) Production method for dihydroxyindoles
EP3118194A4 (en) Method for producing 2-acyliminopyridine derivative
PL3448159T3 (pl) Sposób wytwarzania niesmażonych nuggetów
EP3398929A4 (en) PROCESS FOR PREPARING ALPHA-ALPHA-DIFLUORACETALDEHYDE
PL3299394T3 (pl) Sposób wytwarzania zmodyfikowanych ksylopolisacharydów
ZA201805537B (en) Method for producing sulfoxide derivative
IL255093A0 (en) A method for the production of levoglucosenon
PL3511315T3 (pl) Sposób wytwarzania n-metylo-para-anizydyny